Israeli biotechnology firm, Kamedis seeks Chinese dermo-cosmetic players

According to the founders, Kamedis is specialised in leveraging a state-of-the-art herbal extraction process that best uses herbal extracts to treat skin conditions such as atopic dermatitis, psoriasis, seborrhea and acne.

While the brand has been established in Israel and has done all its research and development there, the founders say the heart and soul of the company is at its' manufacturing plant in China.

In recent years, companies such as Herborist and Inoherb have introduced TCM dermo-cosmetic products, which became well known, and the execs behind this brand believe that the market is now ready for more advanced clinically tested products.

"Chinese consumers have a long history of valuing natural medicines, so we expect to gain a significant share of this extremely fast growing market. As we are combining the strengths of western technologies with powerful TCM knowledge​," says Kamedis executive vice president, Nadav Sade.

Skin care products based on 500 traditional Chinese herbs​

Since it's launch just over 16 years ago, Kamedis has been working on skin care products based on the screening of over 500 traditional Chinese herbs.

The move into China follows the brand gaining significant market share in Israel, Europe and the US.

"We are looking to establish a strategic partnership with one of the large Chinese dermo-cosmetics players​," says Sade.

"Our products are supported by clinical trials and are based on the TCM approach. Hence, we are probably the only TCM Chinese based dermo-cosmetic brand that is proven clinically to treat skin disorders​," he adds.

The company's founders have already met with leading Chinese companies in the area of dermo-cosmetics, and expect to choose a strategic marketing partner within the next six months.

Dermo-cosmetics​

Dermo-cosmetics are recommended for specific skin care needs and the market represents 4.4% of the global beauty market, valued at about €7.6 billion.

The segment is in a strong position, outpacing the global beauty market, and with 1 in 4 skin care products sales in Western Europe taking place in pharmacies or health and beauty shops.

Whereas the global beauty market increased by 3.8% in 2013, the dermo-cosmetics sector experienced a 4.8% growth rate, led by a vital Western Europe market and accelerated development in new markets such as China and Latin America.